Seres Therapeutics, Inc. Public Market Comparables
Find the most relevant public market comparables for Seres Therapeutics, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Seres Therapeutics, Inc. is a clinical-stage company focused on improving patient outcomes in medically vulnerable populations through novel live biotherapeutics. The company develops and researches ecobiotic microbiome therapeutics designed to restore health by repairing the function of a dysbiotic microbiome. They focus on treating dysbiosis in the colonic microbiome.
Business Model
Developing and commercializing live biotherapeutic products targeting various medical conditions, primarily focusing on microbiome therapeutics.
Target Customers
Medically vulnerable populations, including patients undergoing allogeneic hematopoietic stem cell transplants (allo-HSCT), those with recurrent Clostridium difficile infection (CDI), ulcerative colitis, metastatic melanoma, and other conditions.
Specific Focus
Development of live biotherapeutics to treat diseases through modulation of the microbiome.
Location
Cambridge, Massachusetts
CEO
Eric Shaff
Industry
Life sciences
Sub Sector
Microbiome Therapeutics
3yr Revenue Growth
280%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Seres Therapeutics, Inc. in the Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Seres Therapeutics, Inc.? Our platform provides detailed analysis of Seres Therapeutics, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Seres Therapeutics, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Seres Therapeutics, Inc. Compset
As a leading player in the Life sciences industry within the Biotechnology sector, Seres Therapeutics, Inc. operates in the specialized Microbiome Therapeutics sub-sector. Understanding how Seres Therapeutics, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Microbiome Therapeutics space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Aclaris Therapeutics Inc.
Biotechnology • Life sciences
Aclaris Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics (identifying and developing therapies for immuno-inflammatory diseases) and contract research (providing laboratory services). A majority of its revenue comes from the therapeutics segment.
inKind
Fintech • Fintech
inKind is a fintech company that provides funding to restaurants in exchange for food and beverage credits that can be redeemed by consumers through their app. The company offers an innovative funding structure, providing restaurants with low-cost capital and connecting them with a large base of consumers.
Site 20/20
Technology • Hardware & semiconductors (including electronic devices)
Site 20/20 is a Canadian technology company that develops and provides smart traffic control systems, primarily focused on improving safety and efficiency at road construction and work sites. Their flagship product, the Guardian SmartFlagger, replaces traditional human flaggers with a semi-automated system combining a tablet interface with advanced technology and intelligent portable traffic lights.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Seres Therapeutics, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free